Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Surgnova Healthcare Technologies
Xicheng District, China
D
251-500 Employees
2015
Key takeaway
Surgnova is a company focused on developing advanced surgical systems and instruments, supported by a robust R&D center and multiple patented technologies. Their expertise in medical innovation may contribute to advancements in the field of nanomedicine.
Reference
Core business
Surgnova Healthcare Technologies
SYNCHRONY PHARMA LIMITED
Huangpu District, China
D
1-10 Employees
-
Key takeaway
CNX Therapeutics is a European pharmaceutical company focused on improving patient lives through a growing portfolio of injectable medicines and strategic partnerships. Their commitment to commercial excellence and innovative approaches aligns with advancements in fields like nanomedicine.
Reference
Core business
CNX Therapeutics - Building a Healthier World.
Navix Medical Ltd.
Kowloon, China
D
11-50 Employees
2018
Key takeaway
Navix Medical specializes in supporting MedTech businesses in expanding internationally, connecting them with global professionals in sales, marketing, and medical affairs. Their focus on the life sciences industry, particularly medical devices and biotech, aligns with the innovative nature of nanomedicine.
Reference
Core business
Disruptive solutions for Life Sciences - Navix Medical
We offer disruptive solutions for Life Sciences industry. Our goal is to help bring your innovation closer to patients in all markets.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Genemedi Biotech
Huangpu District, China
D
11-50 Employees
2012
Key takeaway
GeneMedi Vision focuses on developing innovative solutions for the therapeutics and diagnostics industry, particularly in gene therapy. Their use of advanced manufacturing techniques and novel design approaches positions them to address unmet needs in this evolving field.
Reference
Core business
GeneMedi | Innovative solution for therapeutics and diagnostics industry.
AlpaLife
Shenzhen, China
D
11-50 Employees
2016
Key takeaway
AlpalifeBio utilizes advanced nanobody screening technology, integrating protein chemistry and molecular pharmacology to enhance antibody drug discovery. Their focus on nanobodies, which are small and unique antibodies, supports innovative approaches in drug development.
Reference
Core business
AlpalifeBio - Dedicated to Support Your Novel Nanobody/VHH and GPCR-targeted Drug Development-AlpalifeB Inc
neoX Biotech
Dongcheng District, China
D
11-50 Employees
2018
Key takeaway
neoX is a biotech company that specializes in the research and development of macromolecular and multispecific drugs, particularly in immuno-oncology. Their innovative platform for characterizing protein-protein interactions (PPI) enhances early therapeutic discovery, which is crucial in the evolving field of nanomedicine.
Reference
Core business
neoX Biotech
MaxNova Medical
Hong Kong Island, China
D
51-100 Employees
2020
Key takeaway
MaxNova is a medical technology company focused on transforming innovative medical technologies, particularly in neurological health, into accessible solutions that improve patient outcomes. Their commitment to open innovation and collaboration with industry partners and academic institutions enhances their capability to develop cutting-edge neurotech advancements.
Reference
Core business
Innovative MedTech Solutions | Commercialization | Distribution
OncoGenerix
China
D
251-500 Employees
2009
Key takeaway
OncoGenerix specializes in injectable process development and manufacturing, offering a comprehensive range of services that ensure compliance with major regulatory standards. Their focus on advanced aseptic manufacturing technology and a robust quality management system positions them as a key player in the production of high-quality injectable products.
Reference
Core business
OncoGenerix - Home
Innocare
Changping District, China
D
51-100 Employees
2013
Key takeaway
InnoCare Pharma Limited is focused on discovering and developing innovative drugs for cancer and autoimmune diseases, utilizing a fully integrated biopharmaceutical platform that enhances operational efficiency and quality control throughout the drug development cycle.
Reference
Core business
InnoCare Pharma Limited | Dedicated and Deliver
Shanghai Medicilon Inc.
Huangpu District, China
D
11-50 Employees
2004
Key takeaway
Medicilon is a contract research organization that offers integrated preclinical research services, including platforms for antibody drug discovery and cell & gene therapy. This focus on innovative R&D services positions Medicilon as a key player in advancing pharmaceutical developments.
Reference
Service
Drug development services-R&D Services | Medicilon
Medicilon has an integrated R&D platform for pre-clinical CRO service experience, which has built a comprehensive technology platform covering key technologies of drug discovery.
Technologies which have been searched by others and may be interesting for you:
When exploring the nanomedicine industry in China, it is crucial to consider several key factors. The regulatory environment plays a vital role, as the Chinese government has been actively developing policies to promote innovation while ensuring safety and efficacy in nanomedicine products. Familiarity with the National Medical Products Administration (NMPA) guidelines and assessment processes is essential for navigating approvals. Additionally, the competitive landscape in China is rapidly evolving, with numerous startups and established firms vying for market share. Understanding the strengths and weaknesses of these companies can provide insights into potential partnerships or investment opportunities. The market is also influenced by China's commitment to biotechnology and healthcare improvements, which presents significant growth potential. Challenges such as intellectual property concerns and the need for skilled professionals in the field may arise. Environmental issues related to the production and disposal of nanomaterials must also be carefully evaluated, as sustainability practices are increasingly important in the industry. Finally, the global relevance of the Chinese nanomedicine market cannot be overlooked, as international collaborations and research initiatives are on the rise, further integrating China into the global nanotechnology landscape.
Some interesting numbers and facts about your company results for Nanomedicine
| Country with most fitting companies | China |
| Amount of fitting manufacturers | 228 |
| Amount of suitable service providers | 114 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2004 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Nanomedicine
What are related technologies to Nanomedicine?
Based on our calculations related technologies to Nanomedicine are Glass, Superconductors, High-Performance Materials, Raw Materials, Phase Change Materials
Which industries are mostly working on Nanomedicine?
The most represented industries which are working in Nanomedicine are Medical, Biotechnology, Other, Pharmaceuticals, Healthcare
How does ensun find these Nanomedicine Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.